Sailaja Pullela

Director, Clinical Trial Transparency at Moderna

Speaker

Sailaja is the Director & Head of Clinical Trial Transparency and Disclosures at Moderna, where she leads efforts in registry and results disclosure, redaction operations, plain language summaries, and data sharing. She spearheads the implementation of the EU Clinical Trials Regulation (EU CTR) at the company level, ensuring operational readiness by establishing governance frameworks and regulatory procedures for CTIS submissions. Sailaja ensures compliance with global regulations, including Health Canada PRCI and EMA Policy 0070, while championing plain language summaries and initiatives rooted in Health Literacy principles to enhance patient and public communications.

With over 24 years of experience spanning academia and industry, Sailaja possesses cross-functional expertise in clinical research, pharmacovigilance, regulatory processes, project management, and clinical trial transparency. She is deeply passionate about driving innovations in life sciences, with a focus on improving clinical trial disclosure and fostering trust through transparency.